Internal Medicine, Infectious Disease · McAllen, TX
NPI
1437412533
Since 2012
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1200 E Savannah Ave Ste 16
McAllen, TX, 78503
Phone (956) 631-3344
Groups this clinician bills Medicare through
Medicare paid, 2024
$112K
1,383 services
Medicare patients, 2024
310
Average age 74
Drug cost, 2024
$586K
1,810 prescriptions
Company payments, 2025
$174
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Miguel E Morilla Holguin was code 99232 (hospital e&m - subsequent), 713 times for 200 patients. In total Miguel E Morilla Holguin billed 1,383 services in 10 codes, and Medicare paid $112K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 713 | 200 | $59.84 | $43K |
| 99233 Hospital E&M - Subsequent | Facility | 272 | 129 | $89.15 | $24K |
| 99223 Hospital E&M - Initial | Facility | 199 | 177 | $128.81 | $26K |
| 99222 Hospital E&M - Initial | Facility | 107 | 92 | $99.08 | $11K |
| 99214 Office E&M - Established | Office | 77 | 57 | $92.22 | $7,101 |
By year: 2022 $137K for 1,616 services; 2023 $113K for 1,314 services; 2024 $112K for 1,383 services.
Medicare prescription drug claims, 2024
In 2024, the drug Miguel E Morilla Holguin prescribed most often to Medicare patients was Daptomycin, with 258 prescriptions and refills. In total Miguel E Morilla Holguin wrote 1,810 Medicare prescriptions that cost $586K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 258 | 258 | 76 | $123K |
| Ceftriaxone Ceftriaxone Sodium | 120 | 120 | 47 | $7,749 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 119 | 119 | 42 | $24K |
| Doxycycline Hyclate Generic | 111 | 112 | 71 | $1,449 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 110 | 110 | 89 | $546 |
| Meropenem Generic | 94 | 94 | 44 | $14K |
| Minocycline Hcl Generic | 79 | 81 | 55 | $1,724 |
| Ertapenem Ertapenem Sodium | 77 | 77 | 36 | $33K |
| Levofloxacin Generic | 70 | 70 | 66 | $231 |
| Metronidazole Generic | 68 | 74 | 66 | $1,137 |
| Vancomycin Hcl Generic | 66 | 66 | 28 | $4,993 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 57 | 57 | Under 11 | $231K |
| Cefdinir Generic | 52 | 52 | 51 | $702 |
| Cefepime Hcl Generic | 48 | 48 | 14 | $5,903 |
| Linezolid Generic | 48 | 48 | 43 | $8,342 |
Brand drugs: 123 claims; generic drugs: 1,687 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Miguel E Morilla Holguin $174 ($174 in general payments such as food, travel and fees) from 2 companies. The largest payer was Melinta Therapeutics, LLC with $142.
| Company | Payments | Amount |
|---|---|---|
| Melinta Therapeutics, LLC | 4 | $142 |
| Merck Sharp & Dohme LLC MRK | 1 | $31.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.